ICICI Direct: Healthcare Sector Q2 Earnings Preview - Exports To Drive Growth As Normalised Domestic Growth Yet To Resume
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Direct Report
The ICICI-Direct healthcare universe is expected to post YoY growth of 1.5% to Rs 35,944 crore on the back of currency driven growth in U.S. formulations even as domestic growth is crawling back to normal.
While domestic growth is still expected to continue to be impacted due to weak demand (acute segment) and lower medical representative footfalls, U.S. formulations are expected to grow due to ramp-up in specialty products and new launches supported by currency tailwinds.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.